Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes
about
Influence of aspirin or heparin on platelet function and postoperative blood loss after coronary artery bypass surgeryReverse effect of aspirin: is the prothrombotic effect after aspirin discontinuation mediated by cyclooxygenase 2 inhibition?Prothrombotic and hemorrhagic effects of aspirin.Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgeryThrombotic events associated to aspirin therapy.The role of aspirin in post-polypectomy bleeding--a retrospective survey.Renal biopsy practice: What is the gold standard?The role of point-of-care assessment of platelet function in predicting postoperative bleeding and transfusion requirements after coronary artery bypass graftingDiscontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary careRisk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.Use of drug-eluting balloon coronary intervention prior to living donor kidney transplantation.Management of patients with acute coronary syndromes in real-world practice in Italy: an outcome research study focused on the use of ANTithRombotic Agents: the MANTRA registryBridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.Discontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease.Perioperative complications following preoperative cessation of antithrombotic agents for total knee arthroplasty: A retrospective study.Cangrelor: a novel P2Y12 receptor antagonist.Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.The impact of antiplatelet medication on hand and wrist surgery.Perioperative management of antiplatelet-drugs in cardiac surgery.Antiplatelet drug therapy: role of pharmacodynamic and genetic testing.Role of antiplatelet therapy in secondary prevention of acute coronary syndrome.Antiplatelet therapy in ENT surgery: a review.Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011.Perioperative stroke risk in nonvascular surgery.The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day.Perioperative management of antiplatelet therapy in patients with drug-eluting stents.Optimizing the use of aspirin for cardiovascular prevention.Bridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedside.Algorithm for anticoagulation management in geriatric hip fracture patients--Surgeons save Blood.Late and very late drug-eluting stent thrombosis in the immediate postoperative period after antiplatelet withdrawal: a retrospective study.Perioperative management of and recommendations for antithrombotic medications in dermatological surgery.Ophthalmic patients on antithrombotic drugs: a review and guide to perioperative management.The great ESCAPE - a clinical pharmacologist's journey in stroke research.Risk of Hemorrhage Attributed to Underlying Chronic Diseases and Uninterrupted Aspirin Therapy of Patients Undergoing Minor Oral Surgical Procedures: A Retrospective Cohort Study.Aspirin Use Prior to Coronary Artery Bypass Grafting Surgery: a Systematic Review.Should aspirin be stopped before carpal tunnel surgery? A prospective study.Safety of dual antiplatelet therapy in daily cardiology practice.Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.Effects of preoperative aspirin on perioperative platelet activation and dysfunction in patients undergoing off-pump coronary artery bypass graft surgery: A prospective randomized study.Dual anti-platelet therapy and dento-alveolar surgery. How do we manage patients on anti-platelet medication?
P2860
Q28195148-080570F3-1E1F-44F7-BBE8-0485459D3450Q33323279-55424B74-C8F6-43F1-B74C-E5FEA673BED5Q33349385-5A76A780-1FED-4A1E-A3F5-83885E5A4645Q33755419-52C95543-2A8C-4724-90B7-D851C35C1273Q34111104-B9C72998-E5DE-46A0-AF04-D598E34ED2A5Q34437063-DC8F51D3-81F0-40C0-A921-450AFA4AC288Q34453300-BA6C3AE1-D28F-461E-BF9A-466F3B8F1669Q34457019-FF5E6AA6-127A-429C-B625-036045AEAC75Q35116433-D607EADD-9899-4D3F-99AC-F13AF2D06CA9Q35117393-9EC40F83-7E57-4F7F-9ADE-7D4C72B4A473Q35236546-071E2373-DD1C-49A2-87C6-2B65028AA963Q37141014-376D7717-63B8-454F-AA9C-6A3082668FCAQ37174455-B2A94A8E-41A7-47A1-ABEB-AD044F522C58Q37300872-7D9C4ABA-4129-4F3B-A935-21542BE4EB47Q37467803-F4929722-DC55-415D-BB9A-E24459BD91C6Q37551923-11CED3D6-40EC-4E20-A528-DE9CA18B1220Q37638183-864F15B2-8B92-4B18-B331-E26C619D92B6Q37707869-CE4AFD77-D6D7-432C-94D0-32BBF6C81EF2Q37740975-4CE32068-7541-4F83-9712-8B4889766277Q37882712-48906900-54CC-4235-BB08-988A8B5A52F0Q37953259-42F1D414-E484-476B-93D9-4FBDCE9D15D8Q37969848-EB25C3E0-3A86-4D16-B6C8-EEB3B6A27CD3Q37994187-CAA66E46-9549-4754-960A-9543A236C366Q38037974-12EB50AA-6994-404D-AD79-9BD1AA77616BQ38053481-96D403AF-27B5-42DD-A76D-B2E7E84B8189Q38084549-4D7CFA96-249C-4DDD-A707-08C36CD7EBADQ38107179-B78B11E0-D061-40B7-A1C3-29D586A23F9CQ38165873-38F30D7F-68D2-4850-89C0-C0DAA6CFA7F4Q38195191-F0820C39-ECF7-4286-AA92-D720BFF2250EQ38228498-01683B88-3BEF-46C9-AA74-F84FEB8FECE7Q38241785-0AFBAACB-F781-4D17-8CAF-E0DB39F4E6DCQ38271548-98B96B5B-7795-45D9-A0B8-06EE561500F0Q38560216-510A42E8-7168-4A38-B4F3-1C3774A41E1CQ38729616-3D3B0CA9-F58D-4B1C-81E1-D74E09D2C9BEQ39141574-D4C643D5-7B52-4C37-96A0-7D5E539DDC2FQ39218594-04F468B7-03B3-458B-9C06-4D53850F4383Q40610419-76BD6A13-BAFF-456B-B007-0F66D35D1986Q40783276-E5DDC357-4F39-4BAE-806D-B081F4D1920AQ41034693-29F97928-F490-493C-AAEC-57ABE9CD89F2Q41725868-3D3B55CB-4564-4075-BB42-06A1AA42A5B9
P2860
Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Impact of prior use or recent ...... ts on acute coronary syndromes
@ast
Impact of prior use or recent ...... ts on acute coronary syndromes
@en
Impact of prior use or recent ...... ts on acute coronary syndromes
@nl
type
label
Impact of prior use or recent ...... ts on acute coronary syndromes
@ast
Impact of prior use or recent ...... ts on acute coronary syndromes
@en
Impact of prior use or recent ...... ts on acute coronary syndromes
@nl
prefLabel
Impact of prior use or recent ...... ts on acute coronary syndromes
@ast
Impact of prior use or recent ...... ts on acute coronary syndromes
@en
Impact of prior use or recent ...... ts on acute coronary syndromes
@nl
P2093
P1433
P1476
Impact of prior use or recent ...... ts on acute coronary syndromes
@en
P2093
B Blanchet
J L Golmard
J P Collet
J P Metzger
M L Tanguy
N Vignolles
R Choussat
P304
P356
10.1161/01.CIR.0000145171.89690.B4
P407
P577
2004-10-19T00:00:00Z